Bristol Myers Squibb Stock Analysis
| BMYMP Stock | USD 800.00 40.00 5.26% |
Bristol Myers Squibb is overvalued with Real Value of 684.39 and Hype Value of 800.0. The main objective of Bristol Myers pink sheet analysis is to determine its intrinsic value, which is an estimate of what Bristol Myers Squibb is worth, separate from its market price. There are two main types of Bristol Myers' stock analysis: fundamental analysis and technical analysis.
The Bristol Myers pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Bristol |
Bristol Pink Sheet Analysis Notes
The company last dividend was issued on the 1st of December 2022. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.The quote for Bristol Myers Squibb is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bristol Myers Squibb please contact the company at 212-546-4000 or go to http://www.bms.com.Bristol Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.11 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 21st of July, Bristol Myers shows the Downside Deviation of 4.05, risk adjusted performance of 0.0539, and Mean Deviation of 1.02. Bristol Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bristol Myers Squibb Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Bristol Myers for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Bristol Myers Squibb short-term fluctuations and highlight longer-term trends or cycles.
Bristol Myers Outstanding Bonds
Bristol Myers issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bristol Myers Squibb uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bristol bonds can be classified according to their maturity, which is the date when Bristol Myers Squibb has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BRISTOL MYERS SQUIBB Corp BondUS110122AB49 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| BRISTOL MYERS SQUIBB Corp BondUS110122BB30 | View | |
| BRISTOL MYERS SQUIBB Corp BondUS110122AX68 | View | |
| US110122AP35 Corp BondUS110122AP35 | View | |
| BRISTOL MYERS SQUIBB Corp BondUS110122AU20 | View | |
| BMY 37 15 MAR 52 Corp BondUS110122DW58 | View | |
| BMY 39 15 MAR 62 Corp BondUS110122DX32 | View |
Bristol Myers Predictive Daily Indicators
Bristol Myers intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bristol Myers pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 800.0 | |||
| Day Typical Price | 800.0 | |||
| Price Action Indicator | 20.0 | |||
| Period Momentum Indicator | 40.0 |
Bristol Myers Forecast Models
Bristol Myers' time-series forecasting models are one of many Bristol Myers' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol Myers' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Bristol Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bristol Myers prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bristol shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bristol Myers. By using and applying Bristol Pink Sheet analysis, traders can create a robust methodology for identifying Bristol entry and exit points for their positions.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Bristol Myers to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Additional Tools for Bristol Pink Sheet Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.